Home >> Research Area >>Tyrosine Kinase/Adaptors>>c-MET>> MK-8033 hydrochloride

MK-8033 hydrochloride

C-Met/Ron inhibitor CAS# 1283000-43-0

MK-8033 hydrochloride

Catalog No. BCC4040----Order now to get a substantial discount!

Product Name & Size Price Stock
MK-8033 hydrochloride:5mg $359.00 In stock
MK-8033 hydrochloride:10mg $610.00 In stock
MK-8033 hydrochloride:25mg $1436.00 In stock
MK-8033 hydrochloride:50mg $2513.00 In stock
Molarity Calculator Dilution Calculator Send Mail Directly
Related Products
  • (-)-MK 801

    Catalog No.:BCC4593
    CAS No.:121917-57-5
  • Ro 25-6981

    Catalog No.:BCC4158
    CAS No.:169274-78-6
  • Felbamate

    Catalog No.:BCC4904
    CAS No.:25451-15-4
  • Flupirtine

    Catalog No.:BCC4282
    CAS No.:56995-20-1
  • (+)-MK 801

    Catalog No.:BCC1288
    CAS No.:70449-94-4

Quality Control of MK-8033 hydrochloride

Quality Control & MSDS

Number of papers citing our products

Chemical structure

MK-8033 hydrochloride

3D structure

Chemical Properties of MK-8033 hydrochloride

Cas No. 1283000-43-0 SDF Download SDF
PubChem ID 51030992 Appearance Powder
Formula C25H22ClN5O3S M.Wt 507.99
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : < 1 mg/mL (insoluble or slightly soluble)
Chemical Name 1-[2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridin-9-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide;hydrochloride
SMILES CN1C=C(C=N1)C2=CN=C3C=CC4=C(C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)C(=O)C3=C2.Cl
Standard InChIKey BKIQDRGTLKPYCL-UHFFFAOYSA-N
Standard InChI InChI=1S/C25H21N5O3S.ClH/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21;/h2-13,15,29H,14,16H2,1H3;1H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of MK-8033 hydrochloride

DescriptionMK8033 Hcl is a novel and specific dual ATP competitive c-Met/Ron inhibitor (IC50=1 nM Wt c-Met) under investigation as a treatment for cancer. IC50 Value: 1 nM (Wt c-Met); 2.0 nM (c-Met N1100Y) [1] Target: c-Met in vitro: MK-8033 binds 3-fold more tightly to phosphorylated c-Met kinase domain (Kd= 3.2 nM) than to its unphosphorylated counterpart (Kd = 10.4 nM). Signigicantly, MK-8033 potently inhibits kinase activity of three oncogenic c-Met activation loop mutants, Y1230C, Y1230H, and Y1235D (IC50s ranging from 0.6 to 1 nM at 50 uM ATP) in addition to other c-Met activating mutants N1100Y and M1250T. MK-8033 potently inhibited GTL-16 proliferation with an IC50 of 582 ± 30 nM. By contrast the HCT116 cell line, which does not harbor basal c-Met activation, was not inhibited by MK-8033 (IC50 > 10000 nM) [1]. MK-8033 radiosensitized the high-c-Met-expressing EBC-1 and H1993 cells but not the low-c-Met-expressing cell lines A549 and H460. However, irradiation of A549 and H460 cells increased the expression of c-Met protein at 30 minutes after the irradiation. Subsequent targeting of this up-regulated c-Met by using MK-8033 followed by a second radiation dose reduced the clonogenic survival of both A549 and H460 cells. MK-8033reduced the levels of radiation-induced phosphorylated (activated) c-Met in A549 cells [2]. in vivo: MK-8033 was orally dosed in GTL-16 tumor xenograft bearing mice. Mice were euthanized 1 h after dosing and tested for p-Met (Y1349) in tumors and MK-8033 concentrations in plasma. At 100 mg/kg,essentially complete inhibition of p-Met (Y1349) was achieved. An in vivo IC50 of 1.3 uM was deduced from the relationship between plasma MK-8033 level and Met pY1349. Treatment with escalating dosed of MK-8033 for 21 days lead to antitumor efficacies in a dose-dependent manner. Dosing at 3, 10, 30, and 100 mg/kg resulted in 22, 18, 57, and 86% tumor growth inhibition, respectively, relative to tumor from vehicle-treated mice.

References:
[1]. Northrup AB, et al, Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated [2]. Bhardwaj V, et al. C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression. J Thorac Oncol. 2012 Aug;7(8):1211-7.

MK-8033 hydrochloride Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

MK-8033 hydrochloride Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of MK-8033 hydrochloride

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.9685 mL 9.8427 mL 19.6854 mL 39.3709 mL 49.2136 mL
5 mM 0.3937 mL 1.9685 mL 3.9371 mL 7.8742 mL 9.8427 mL
10 mM 0.1969 mL 0.9843 mL 1.9685 mL 3.9371 mL 4.9214 mL
50 mM 0.0394 mL 0.1969 mL 0.3937 mL 0.7874 mL 0.9843 mL
100 mM 0.0197 mL 0.0984 mL 0.1969 mL 0.3937 mL 0.4921 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on MK-8033 hydrochloride

MK-8033 hydrochloride is a specific dual inhibitor of c-Met/Ron with the IC50 value of 1.3nM for c-Met [1].

MK-8033 hydrochloride has been reported to potently inhibit c-Met/HGF-dependent cellular phenotypes in vitro. The studies shown that MK-8033 inhibit the phosphorylation of Y1349 of c-Met with the IC50 value of 0.03μM and proliferation with the IC50 value of 0.58μM in the GTL-16 cell lines. In addition, MK-8033 hydrochloride has also been revealed to preferentially bind to and inhibit the catalytic activity of activated c-Met kinase. Furthermore, MK-8033 hydrochloride has been noted to bind 3-fold more tightly to phosphorylated counterpart with the Kd value of 10.4nM in a BIAcore-based direct binding assay. Apart from these, MK-8033 hydrochloride has shown a inhibitory effect on WT and oncogenic c-Met at 50μM ATP with the IC50 values of 1.3nM, 1.0nM, 0.6nM and 0.6nM for WT c-Met, c-Met(Y1230C), c-Met(Y1230H) and c-Met(Y1235D), respectively [1].

References:
[1] Northrup AB1, Katcher MH, Altman MD, Chenard M, Daniels MH, Deshmukh SV, Falcone D, Guerin DJ, Hatch H, Li C, Lu W, Lutterbach B, Allison TJ, Patel SB, Reilly JF, Reutershan M, Rickert KW, Rosenstein C, Soisson SM, Szewczak AA, Walker D, Wilson K, Young JR, Pan BS, Dinsmore CJ. Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met. J Med Chem. 2013 Mar 28;56(6):2294-310. doi: 10.1021/jm301619u. Epub 2013 Mar 18.

Featured Products
New Products
 

Description

MK8033 Hcl is a novel and specific dual ATP competitive c-Met/Ron inhibitor (IC50=1 nM Wt c-Met) under investigation as a treatment for cancer.

Keywords:

MK-8033 hydrochloride,1283000-43-0,Natural Products,c-MET, buy MK-8033 hydrochloride , MK-8033 hydrochloride supplier , purchase MK-8033 hydrochloride , MK-8033 hydrochloride cost , MK-8033 hydrochloride manufacturer , order MK-8033 hydrochloride , high purity MK-8033 hydrochloride

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result:

      BioCrick BioTech
      88# Keyuan road,Hi-Tech Zone
      Chengdu, Sichuan 610042, PRC
      Email: info@biocrick.com
      Tel:86-28-8543-3893
      Follow us:

      BioCrick is one of the biggest natural products manufacturers in Asia

      Our products can be used as reference standards,inhibitors in pharmacological research

      Our MISSION is to provide Best-in-class High-purity natural compounds to researchers all around the world

      © 2007-2024 BioCrick BioTech. All rights reserved.  sitemap

      Menu Close
      Search Now